Analyst Ratings for Galena Biopharma (GALE)
GALE Rating Summary
GALE Price Target Summary
- Highest: $6.00 (Aegis Capital)
- Lowest: $2.50 (Piper Jaffray)
- Average: $4.00
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$4.00 (+56.3%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/22/2013 | JMP Securities | New Coverage | Market Outperform (N/A) |
5.00 (N/A) |
2.50 | 2.56 | 2.4% | Details |
| 3/25/2013 | Needham & Company | New Coverage | Buy (N/A) |
3.50 (N/A) |
1.93 | 2.56 | 32.64% | Details |
| 12/31/2012 | Piper Jaffray | New Coverage | Overweight (N/A) |
2.50 (N/A) |
1.50 | 2.56 | 70.67% | Details |
| 11/28/2012 | Aegis Capital | New Coverage | Buy (N/A) |
6.00 (N/A) |
1.58 | 2.56 | 62.03% | Details |
| 11/27/2012 | Dawson James | New Coverage | Market Outperform (N/A) |
3.00 (N/A) |
1.69 | 2.56 | 51.48% | Details |
| 6/4/2012 | Cantor Fitzgerald » Updated 8/15/2012 |
New Coverage | Buy (N/A) |
4.00 (N/A) |
1.29 | 2.56 | 98.45% | Details |
